Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
NCT04383756Phase 1Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2020
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial in liver transplantation (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Use of allogenic banked blood products and Economic cost. Planned start Dec 2020; status: withdrawn.
02
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT04383756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04383756.